Tegretol



Indications and Reactions:

Role Indications Reactions
Primary
Epilepsy 44.9%
Convulsion 12.2%
Trigeminal Neuralgia 9.0%
Hypertension 5.7%
Depression 3.4%
Bipolar Disorder 3.2%
Pain 2.6%
Schizophrenia 2.3%
Neuralgia 1.9%
Insomnia 1.8%
Partial Seizures 1.7%
Constipation 1.6%
Bipolar I Disorder 1.5%
Asthma 1.3%
Temporal Lobe Epilepsy 1.3%
Diabetes Mellitus 1.3%
Anxiety 1.2%
Grand Mal Convulsion 1.1%
Affective Disorder 1.0%
Gastritis 0.9%
Maternal Exposure During Pregnancy 11.6%
Vomiting 10.9%
Convulsion 10.1%
Somnolence 7.4%
White Blood Cell Count Increased 6.7%
White Blood Cell Count Decreased 5.8%
Suicide Attempt 5.3%
Pyrexia 4.8%
Rash 4.5%
Stevens-johnson Syndrome 3.7%
Drug Exposure During Pregnancy 3.6%
Epilepsy 3.5%
Urticaria 3.4%
Tremor 3.3%
Stillbirth 2.9%
Pain 2.6%
Weight Increased 2.6%
Vision Blurred 2.4%
Loss Of Consciousness 2.4%
Weight Decreased 2.2%
Secondary
Epilepsy 32.4%
Product Used For Unknown Indication 11.9%
Drug Use For Unknown Indication 8.1%
Convulsion 7.4%
Trigeminal Neuralgia 5.4%
Depression 5.0%
Hypertension 4.6%
Pain 4.1%
Bipolar Disorder 3.4%
Constipation 2.6%
Insomnia 2.0%
Schizophrenia 1.8%
Cerebral Infarction 1.7%
Anxiety 1.6%
Partial Seizures 1.5%
Affective Disorder 1.4%
Bipolar I Disorder 1.4%
Neuralgia 1.2%
Foetal Exposure During Pregnancy 1.2%
Brief Psychotic Disorder With Marked Stressors 1.1%
Vomiting 12.4%
Convulsion 7.7%
Somnolence 6.9%
White Blood Cell Count Decreased 6.9%
White Blood Cell Count Increased 6.4%
Stevens-johnson Syndrome 6.3%
Weight Decreased 5.4%
Weight Increased 5.4%
Tremor 4.6%
Hyponatraemia 3.8%
Toxic Skin Eruption 3.8%
Vision Blurred 3.8%
Malaise 3.6%
Rash 3.6%
Drug Hypersensitivity 3.5%
Suicide Attempt 3.4%
Epilepsy 3.3%
Pyrexia 3.2%
Nausea 3.0%
Toxic Epidermal Necrolysis 3.0%
Concomitant
Product Used For Unknown Indication 17.3%
Epilepsy 13.6%
Drug Use For Unknown Indication 9.7%
Convulsion 7.1%
Depression 6.2%
Pain 5.6%
Bipolar Disorder 5.5%
Multiple Sclerosis 4.8%
Hypertension 4.7%
Complex Partial Seizures 3.0%
Simple Partial Seizures 2.9%
Schizophrenia 2.4%
Relapsing-remitting Multiple Sclerosis 2.4%
Rheumatoid Arthritis 2.4%
Partial Seizures With Secondary Generalisation 2.2%
Anxiety 2.2%
Trigeminal Neuralgia 2.1%
Insomnia 2.0%
Prophylaxis 1.9%
Asthma 1.9%
Vomiting 10.1%
Weight Increased 10.0%
Weight Decreased 9.0%
Convulsion 8.0%
Somnolence 5.8%
Type 2 Diabetes Mellitus 5.7%
White Blood Cell Count Decreased 5.4%
Pyrexia 4.9%
Epilepsy 4.6%
Urinary Tract Infection 4.3%
Tremor 4.1%
Rash 4.0%
Pain 3.5%
Nausea 3.4%
Drug Ineffective 3.1%
Suicidal Ideation 3.0%
Death 2.8%
Status Epilepticus 2.8%
Vision Blurred 2.8%
Pneumonia 2.7%
Interacting
Epilepsy 24.4%
Schizophrenia 12.1%
Product Used For Unknown Indication 11.4%
Drug Use For Unknown Indication 10.3%
Lymphoma 5.5%
Hypertension 5.1%
Convulsion 4.0%
Partial Seizures 3.6%
Pain 2.9%
Constipation 2.6%
Depression 2.2%
Heart Transplant 2.2%
Schizophrenia, Paranoid Type 2.1%
Hiv Infection 1.9%
Prophylaxis 1.9%
Trigeminal Neuralgia 1.9%
Complex Partial Seizures 1.6%
Convulsion Prophylaxis 1.6%
Insomnia 1.6%
Neuralgia 1.2%
Drug Interaction 25.0%
Somnolence 10.3%
Nausea 5.8%
Hyponatraemia 5.1%
Visual Impairment 5.1%
Tremor 4.5%
Weight Decreased 4.5%
Epilepsy 3.8%
Soliloquy 3.8%
Speech Disorder 3.8%
White Blood Cells Urine Positive 3.8%
Withdrawal Syndrome 3.8%
Paraesthesia 3.2%
Toxicity To Various Agents 3.2%
Anticonvulsant Drug Level Increased 2.6%
Blood Amylase Increased 2.6%
Incoherent 2.6%
Vomiting 2.6%
Accidental Overdose 1.9%
Immunosuppressant Drug Level Increased 1.9%